Background
Background Analysis ofthe patterns of Analysis ofthe patterns of variation in health care costs and the variation in health care costs and the determinants of these costs (including determinants of these costs (including treatment differences) is an increasingly treatment differences) is an increasingly important aspect of research into the important aspect of research into the performance of mental health services. performance of mental health services.
Aims Aims To encourage both investigators
To encourage both investigators ofthe variation in health care costs and the of the variation in health care costs and the consumers of their investigations to think consumers of their investigations to think more critically aboutthe precise aims of more critically aboutthe precise aims of these investigations and the choice of these investigations and the choice of statistical methods appropriate to achieve statistical methods appropriate to achieve them. them.
Method Method We briefly describe examples
We briefly describe examples of regression models that might be of use of regression models that might be of use in the prediction of mental health costs in the prediction of mental health costs and how one might choose which one to and how one might choose which one to use for a particular research project. use for a particular research project.
Conclusions Conclusions If the investigators are
If the investigators are primarily interested in explanatory primarily interested in explanatory mechanisms then they should seriously mechanisms then they should seriously consider generalised linear models (but consider generalised linear models (but with careful attention being paid to the with careful attention being paid to the appropriate error distribution). Further appropriate error distribution).Further insightislikely to be gained throughthe use insightislikely to be gained throughthe use of two-part models.For prediction we of two-part models.For prediction we recommend regression on raw costs using recommend regression on raw costs using ordinary least-square methods.Whatever ordinary least-square methods.Whatever method is used, investigators should method is used, investigators should consider how robusttheir methods might consider how robusttheir methods might be to incorrect distributional assumptions be to incorrect distributional assumptions (particularly in small samples) and they (particularly in small samples) and they should not automatically assume that should not automatically assume that methods such as bootstrapping will allow methods such as bootstrapping will allow them to ignore these problems. them to ignore these problems.
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Analysis of the pattern of variation in indiAnalysis of the pattern of variation in individuals' health care costs and the determividuals' health care costs and the determinants of these costs (including treatment nants of these costs (including treatment differences) is an increasingly important asdifferences) is an increasingly important aspect of research into the performance of pect of research into the performance of mental health services. Econometric modelmental health services. Econometric modelling Jones ling (Kennedy, 1998; is & O 'Donnell, 2002; ) is a rather specialised activity within mental a rather specialised activity within mental health research and, for obvious reasons, health research and, for obvious reasons, is not covered (at least not in sufficient is not covered (at least not in sufficient detail) by standard textbooks on medical detail) by standard textbooks on medical statistics (e.g. health care costs get only statistics (e.g. health care costs get only two very brief entries in Armitage two very brief entries in . The present review aims to fill this 2002). The present review aims to fill this gap. It is our intention neither to give a degap. It is our intention neither to give a detailed picture of how and when each of tailed picture of how and when each of these methods has been used in the mental these methods has been used in the mental health literature nor to appraise the quality health literature nor to appraise the quality of any particular applications. Given the of any particular applications. Given the inevitable space limitations of such a review inevitable space limitations of such a review we will not dwell on many of the technical we will not dwell on many of the technical details but will give a brief summary of details but will give a brief summary of many of the methods that are available many of the methods that are available and indicate how and when they might be and indicate how and when they might be useful. One important area of health ecouseful. One important area of health economics that might not appear to have much nomics that might not appear to have much in common with health econometrics is the in common with health econometrics is the analysis of incremental cost-effectiveness analysis of incremental cost-effectiveness ratios using data from randomised conratios using data from randomised controlled trials. Incremental cost-effectiveness trolled trials. Incremental cost-effectiveness ratios cannot be analysed using regressionratios cannot be analysed using regressionbased methods but Hoch based methods but Hoch et al et al (2002 Hoch et al et al ( ) re-(2002 recently have illustrated how a new approach cently have illustrated how a new approach to cost-effectiveness analysis (based on the to cost-effectiveness analysis (based on the net benefit framework; Stinnett net benefit framework; Tambour 1998; Tambour et al et al, 1998) can lead to , 1998) can lead to the effective use of econometric modelling. the effective use of econometric modelling.
Background Background
The purpose of this review is to enhance The purpose of this review is to enhance readers' ability to understand and appraise readers' ability to understand and appraise research papers and other reports on the research papers and other reports on the prediction of mental health care costs, payprediction of mental health care costs, paying particular attention to the statistical ing particular attention to the statistical methodology, in terms of choice of model, methodology, in terms of choice of model, and to evaluation of the likely future and to evaluation of the likely future performance of the chosen predictive modperformance of the chosen predictive model. Although we would not expect the el. Although we would not expect the typical reader of this journal to be fully typical reader of this journal to be fully aware of the technical pitfalls of analysing aware of the technical pitfalls of analysing costs data, in our view it is vital that, as costs data, in our view it is vital that, as in the critical appraisal of other research in the critical appraisal of other research evidence, readers are familiar with the main evidence, readers are familiar with the main issues and how the authors' interpretations issues and how the authors' interpretations of the results of such studies might be misof the results of such studies might be misleading or mistaken. Whenever possible, we leading or mistaken. Whenever possible, we wish to be able to make our own judgewish to be able to make our own judgements as to the quality of a piece of ments as to the quality of a piece of research rather than having to take the research rather than having to take the views of 'experts' on trust. Other topics, views of 'experts' on trust. Other topics, such as methods of patient selection and such as methods of patient selection and methodological problems concerning meamethodological problems concerning measurement of the actual costs of care for surement of the actual costs of care for individual patients, are extremely importindividual patients, are extremely important but we will not attempt to discuss these ant but we will not attempt to discuss these in detail here. Many of the problems in detail here. Many of the problems concerning the selection of patients to study concerning the selection of patients to study are similar to those that are the usual conare similar to those that are the usual concerns of anyone wishing to make a critical cerns of anyone wishing to make a critical appraisal of prognosis studies and we thereappraisal of prognosis studies and we therefore refer readers to the relevant literature fore refer readers to the relevant literature in this area (Sackett in this area (Sackett et al et al, 1991) . , 1991). Our own interest in the appraisal of the Our own interest in the appraisal of the validity of many past studies of health care validity of many past studies of health care costs and a recent review by Diehr costs and a recent review by Diehr et al et al (1999) have prompted us to question (1999) have prompted us to question whether the methods currently available whether the methods currently available for modelling or predicting health care for modelling or predicting health care costs, other than ordinary least-squares recosts, other than ordinary least-squares regression of logged costs, are widely known gression of logged costs, are widely known in the mental health field. We are not aware in the mental health field. We are not aware of an elementary discussion of the relevant of an elementary discussion of the relevant methodologies but there is a useful study methodologies but there is a useful study illustrating most of the methodological illustrating most of the methodological problems in the context of analysis of variaproblems in the context of analysis of variation in mental health care costs (Kilian tion in mental health care costs (Kilian et al et al, , 2002) . Although it covers most of the same 2002). Although it covers most of the same ground as the present paper, the discussion ground as the present paper, the discussion by Kilian by Kilian et al et al is technically more difficult is technically more difficult than the one presented here. The goal of than the one presented here. The goal of this review is to make these methods more this review is to make these methods more widely accessible to non-specialists and, in widely accessible to non-specialists and, in particular, to the consumers of the resulting particular, to the consumers of the resulting research findings. research findings.
Our intention is to describe and explain Our intention is to describe and explain the competing methods as clearly as possthe competing methods as clearly as possible while keeping the technical details to ible while keeping the technical details to the minimum necessary for this objective. the minimum necessary for this objective. We will use little mathematics, restricting We will use little mathematics, restricting most of it to the definition of the various most of it to the definition of the various indices of the predictive power of the comindices of the predictive power of the competing models. We hope that the present peting models. We hope that the present review can be read and understood by review can be read and understood by clinicians and other mental health workers, clinicians and other mental health workers, although we would hope that it might although we would hope that it might also provide a good starting point for also provide a good starting point for statisticians and health economists who do statisticians and health economists who do not have experience or specialist knowledge not have experience or specialist knowledge of econometric modelling. of econometric modelling.
DEFINING THE GOALS DEFINING THE GOALS OF THE STUDY OF THE STUDY
In reading papers on the prediction of In reading papers on the prediction of mental health costs, one of the striking mental health costs, one of the striking conclusions made concerns the frequent conclusions made concerns the frequent lack of clarity in the authors' aims and this lack of clarity in the authors' aims and this lack of clarity arises from the vague way in lack of clarity arises from the vague way in which they deal with the concept of predicwhich they deal with the concept of prediction. 'Predictive power' refers to a model's tion. 'Predictive power' refers to a model's ability to discriminate between patients ability to discriminate between patients and to account for their cost differences. and to account for their cost differences. Sometimes the authors are content simply Sometimes the authors are content simply to describe differences in the health care to describe differences in the health care costs of different patient groups, usually costs of different patient groups, usually also reporting the results of simple signialso reporting the results of simple significance tests of group differences. This is ficance tests of group differences. This is often accompanied by the use of some sort often accompanied by the use of some sort of regression model that can be used to of regression model that can be used to 'explain' or account for the variation of 'explain' or account for the variation of costs within and between these patient costs within and between these patient groups. Finally (but very rarely is this made groups. Finally (but very rarely is this made explicit) is the aim of being able to predict explicit) is the aim of being able to predict or forecast the costs of future patients or forecast the costs of future patients (either individually or collectively). More (either individually or collectively). More often than not, authors fail to distinguish often than not, authors fail to distinguish between explanatory models and those between explanatory models and those used for forecasting, accordingly giving used for forecasting, accordingly giving very little thought to which statistical very little thought to which statistical technique or group of techniques might be technique or group of techniques might be optimal for a given goal. It is possible, optimal for a given goal. It is possible, and frequently likely, that authors have and frequently likely, that authors have several related aims in the presentation several related aims in the presentation and analysis of their data, but it would be and analysis of their data, but it would be very helpful for the reader if they could be very helpful for the reader if they could be more precise in explaining exactly what more precise in explaining exactly what they are. they are.
To summarise, goals need to be defined To summarise, goals need to be defined precisely and the statistical methods should precisely and the statistical methods should be chosen to fulfil these goals. A model be chosen to fulfil these goals. A model and corresponding fitting method might and corresponding fitting method might be optimal for one particular goal but not be optimal for one particular goal but not the most effective for another. The optimal the most effective for another. The optimal choice of methodology should be depenchoice of methodology should be dependent upon the authors' chosen (and dent upon the authors' chosen (and explicitly stated) aims. A given statistical explicitly stated) aims. A given statistical model might be good as an explanatory model might be good as an explanatory device but poor as a tool for forecasting, device but poor as a tool for forecasting, or vice versa. In practice, however, the or vice versa. In practice, however, the choice of statistical model might not matter choice of statistical model might not matter too much (i.e. the results of the analysis are too much (i.e. the results of the analysis are fairly insensitive or robust to model choice) fairly insensitive or robust to model choice) but, again, both the authors and readers of but, again, both the authors and readers of studies of health costs need to know studies of health costs need to know whether this is likely to be the case. whether this is likely to be the case.
DISTRIBUTIONAL DISTRIBUTIONAL PROPERTIES OF COST DATA PROPERTIES OF COST DATA
Cost data are virtually always highly posiCost data are virtually always highly positively skewed and (at least in the context tively skewed and (at least in the context of the investigations discussed here -this of the investigations discussed here -this would not be true for the analysis of net would not be true for the analysis of net benefits, for example) cannot have negative benefits, for example) cannot have negative values (zero values are possible but, in values (zero values are possible but, in practice, it is also unlikely that a patient practice, it is also unlikely that a patient will incur exactly zero cost). Another will incur exactly zero cost). Another characteristic of this type of data is that characteristic of this type of data is that the variance of the observations increases the variance of the observations increases with their mean (an example of heterowith their mean (an example of heteroscedasticity as opposed to homoscedasticity, scedasticity as opposed to homoscedasticity, the latter implying a constant variance). It the latter implying a constant variance). It is also possible to get what is called censoris also possible to get what is called censoring (incomplete or variable follow-up). In ing (incomplete or variable follow-up). In this situation the data collection stops this situation the data collection stops before some or all of the patients have before some or all of the patients have incurred their full health care costs, so that incurred their full health care costs, so that all we know is that the observed cost is the all we know is that the observed cost is the minimum that has been incurred by a given minimum that has been incurred by a given patient but the exact amount is unknown. patient but the exact amount is unknown. Censoring is not a problem that is unique Censoring is not a problem that is unique to cost data. It is likely to be more familiar to cost data. It is likely to be more familiar to readers in the context of the analysis of to readers in the context of the analysis of times to certain events (times to recovery, times to certain events (times to recovery, relapse or death are three common examrelapse or death are three common examples). Examples of censoring occur when ples). Examples of censoring occur when patients are lost to follow-up prior to the patients are lost to follow-up prior to the end of the data collection period, or, if the end of the data collection period, or, if the cost of an episode of illness is the variable cost of an episode of illness is the variable of interest, termination of the follow-up of interest, termination of the follow-up period prior to the end of the patient's epiperiod prior to the end of the patient's episode of illness. Another possible example is sode of illness. Another possible example is an incomplete measurement of health care an incomplete measurement of health care costs arising from one or two components costs arising from one or two components of the cost incurred by a given patient being of the cost incurred by a given patient being missing from the data file. Here, again, we missing from the data file. Here, again, we know the minimum cost incurred for that know the minimum cost incurred for that patient (the sum of the non-missing compopatient (the sum of the non-missing component costs) but not the total (the sum of the nent costs) but not the total (the sum of the non-missing and missing components). non-missing and missing components). Discussion of censored data is beyond the Discussion of censored data is beyond the scope of the present paper and we refer scope of the present paper and we refer interested readers to Diehr interested readers to Diehr et al et al (1999) (1999) and to discussions of survival analysis (see and to discussions of survival analysis (see . A given population (or sample) of pa-A given population (or sample) of patients can often be thought of as a mixture tients can often be thought of as a mixture of two types. First, there are those who will of two types. First, there are those who will incur little, if any, treatment costs: those incur little, if any, treatment costs: those that attend for assessment, advice or brief that attend for assessment, advice or brief support but do not need access to long-term support but do not need access to long-term care. They may have only a very minor prob care. They may have only a very minor prob--lem or one that is acute but from which lem or one that is acute but from which they make a quick and full recovery. Secthey make a quick and full recovery. Second, there are patients who need varying ond, there are patients who need varying but non-trivial amounts of treatment and but non-trivial amounts of treatment and long-term care. These are the patients who long-term care. These are the patients who may incur quite modest yearly health care may incur quite modest yearly health care costs but need very expensive long-term costs but need very expensive long-term care and support. Thus, the first question care and support. Thus, the first question faced by the statistical modeller, whether faced by the statistical modeller, whether interested in explanation or forecasting, is interested in explanation or forecasting, is whether to try to take this heterogeneity whether to try to take this heterogeneity of the patients (i.e. the group structure) into of the patients (i.e. the group structure) into account. Do we use a one-part model or is account. Do we use a one-part model or is it better to use a two-part model? Before it better to use a two-part model? Before trying to answer this question we first need trying to answer this question we first need to describe what the two types of model to describe what the two types of model are. We also need a more general discussion are. We also need a more general discussion on the choice of regression models. on the choice of regression models.
ONE-OR T WO-PART ONE-OR T WO-PART MODELS ? MODELS ?
At the first stage of a two-part model we try At the first stage of a two-part model we try to discriminate between the two patient to discriminate between the two patient types, that is, we try to predict who will types, that is, we try to predict who will incur substantial costs (group A, say) as incur substantial costs (group A, say) as opposed to those who will cost little or opposed to those who will cost little or nothing (group B). Typically, this will be nothing (group B). Typically, this will be carried out using a multiple logistic regrescarried out using a multiple logistic regression. At the second stage we drop group B sion. At the second stage we drop group B patients from the analysis and then try to patients from the analysis and then try to model the incurred costs in those patients model the incurred costs in those patients who are in group A. Patient characteristics who are in group A. Patient characteristics that distinguish groups A and B might, or that distinguish groups A and B might, or might not, be the same as those that appear might not, be the same as those that appear to be responsible for the variations in the to be responsible for the variations in the costs of those in group B. If the aim is to costs of those in group B. If the aim is to predict (forecast) the total cost for a given predict (forecast) the total cost for a given patient, for example, then this is equal to patient, for example, then this is equal to the sum of two components. The first is the sum of two components. The first is the product of the probability of being in the product of the probability of being in group A and the modelled (expected) cost group A and the modelled (expected) cost if the patient is in group A. The second if the patient is in group A. The second component is the product of the probability component is the product of the probability of being in group B and the modelled cost if of being in group B and the modelled cost if the patient is in group B. In symbols, this is the patient is in group B. In symbols, this is
where where P P( ) is the modelled probability from ( ) is the modelled probability from stage 1, stage 1, E E( ) is the expected or predicted ( ) is the expected or predicted value from stage 2, | means 'given' or 'convalue from stage 2, | means 'given' or 'conditional upon' and X is an indicator of the ditional upon' and X is an indicator of the observed characteristics of the patient; observed characteristics of the patient; E E(Cost|B) is simply the average cost for (Cost|B) is simply the average cost for those patients in group B. If we were conthose patients in group B. If we were concerned with predicting treatment costs (as cerned with predicting treatment costs (as opposed to the total cost to the health seropposed to the total cost to the health service, say) and group B patients are those vice, say) and group B patients are those who do not receive treatment, then who do not receive treatment, then E E(Cost|B) would be zero.
(Cost|B) would be zero. In a one-part model we use a single reIn a one-part model we use a single regression equation to model the costs for gression equation to model the costs for everyone in the data-set (i.e. we do not first everyone in the data-set (i.e. we do not first separate groups A and B). The predicted separate groups A and B). The predicted cost for a given patient with characteristics cost for a given patient with characteristics X is then simply X is then simply E E(Cost|X). (Cost|X). We will assume that the investigator We will assume that the investigator has a clear idea of how to distinguish 'subhas a clear idea of how to distinguish 'substantial' from 'little or nothing' costs based stantial' from 'little or nothing' costs based on his or her knowledge of the population on his or her knowledge of the population being 'When the goal is understanding the system, a 'When the goal is understanding the system, a two-part model seems best because it permits two-part model seems best because it permits the investigator to distinguish factors that affect the investigator to distinguish factors that affect the propensity to use any services from factors the propensity to use any services from factors that affect volume of utilisation once the person that affect volume of utilisation once the person has entered the system . . . For understanding has entered the system . . . For understanding the effect of individual covariates on total costs, the effect of individual covariates on total costs, a one-part model is most useful because it gena one-part model is most useful because it generates a single regression coefficient for each erates a single regression coefficient for each variable and so can be interpreted easily'. variable and so can be interpreted easily'.
We will defer discussion on accuracy of We will defer discussion on accuracy of forecasts until later. Before moving on, forecasts until later. Before moving on, however, it should be noted that an inthowever, it should be noted that an intelligent data analyst is likely to make a elligent data analyst is likely to make a decision concerning the use of a one-part decision concerning the use of a one-part or two-part model at least partly on the baor two-part model at least partly on the basis of his or her prior knowledge concerning sis of his or her prior knowledge concerning the heterogeneity of the population of the heterogeneity of the population of patients under study and also from the patients under study and also from the way the sample of patients for analysis way the sample of patients for analysis has been chosen. The analyst may have dehas been chosen. The analyst may have deliberately selected a relatively homogeneous liberately selected a relatively homogeneous subsample of patients prior to any further subsample of patients prior to any further statistical analyses. statistical analyses.
Having chosen which of the two apHaving chosen which of the two approaches to use, we are still faced with the proaches to use, we are still faced with the problem of how to choose an appropriate problem of how to choose an appropriate regression model for either total costs regression model for either total costs (one-part model) or costs in those that enter (one-part model) or costs in those that enter the system (two-part model). This is the the system (two-part model). This is the subject of the following section. Readers subject of the following section. Readers wishing to read more on two-part modelwishing to read more on two-part modelling are referred to Duan ling are referred to Duan et al et al (1983 Duan et al et al ( , (1983 Duan et al et al ( , 1984 , and the review of 1984), (1999) .
.
CHOICE OF REGRESSION CHOICE OF REGRESSION MODEL MODEL
The simplest approach is to model the The simplest approach is to model the observed costs directly using multiple observed costs directly using multiple regression; the fitting is done using the regression; the fitting is done using the amiliar ordinary least-squares algorithm. amiliar ordinary least-squares algorithm. Multiple regression, however, assumes that Multiple regression, however, assumes that the effects of the predictive factors are the effects of the predictive factors are additive. Furthermore, ordinary least additive. Furthermore, ordinary least squares is not the optimal fitting method squares is not the optimal fitting method (in the sense of producing parameter (in the sense of producing parameter estimates with maximum precision) when estimates with maximum precision) when the distribution of the errors (differences the distribution of the errors (differences between observed and modelled costs) has between observed and modelled costs) has a non-constant variance (heteroscedastia non-constant variance (heteroscedasticity). The latter characteristics of the data, city). The latter characteristics of the data, together with non-normality, will also invatogether with non-normality, will also invalidate tests of significance associated with lidate tests of significance associated with the model-fitting process, and estimates of the model-fitting process, and estimates of the standard errors and confidence intervals the standard errors and confidence intervals for the parameters. Ordinary least-squares for the parameters. Ordinary least-squares modelling of raw cost data -based on modelling of raw cost data -based on invalid distributional assumptions -can invalid distributional assumptions -can (and does) also produce invalid (i.e. nega-(and does) also produce invalid (i.e. negative) estimates of costs for some patients. tive) estimates of costs for some patients. It is not surprising, then, that investigators It is not surprising, then, that investigators might be tempted to use methods other might be tempted to use methods other than ordinary least-squares modelling of than ordinary least-squares modelling of raw cost data (but see below). raw cost data (but see below). If one takes logarithms of the observed If one takes logarithms of the observed cost data, this transformation usually will cost data, this transformation usually will have two consequences: a considerable have two consequences: a considerable reduction in the skewness of the data, reduction in the skewness of the data, although complete symmetry is unlikely to although complete symmetry is unlikely to be achieved in practice; and stability of be achieved in practice; and stability of the variance (i.e. the variability of the the variance (i.e. the variability of the observed costs will not increase with their observed costs will not increase with their mean). Both of these consequences lead to mean). Both of these consequences lead to better performance of ordinary leastbetter performance of ordinary leastsquares regression methods. Examples of squares regression methods. Examples of the use of this approach can be found in the use of this approach can be found in Amaddeo Amaddeo et al et al (1998) and Bonizzato (1998) and Bonizzato et al et al (2000) . The method is (usually) implicitly (2000) . The method is (usually) implicitly based on a multiplicative model for the based on a multiplicative model for the actual costs (including a multiplicative actual costs (including a multiplicative error term). There is a problem if there error term). There is a problem if there are observed costs of zero (the logarithm are observed costs of zero (the logarithm of zero is undefined) but this is often remeof zero is undefined) but this is often remedied by adding a small constant (unity, for died by adding a small constant (unity, for example) prior to the logarithmic transforexample) prior to the logarithmic transformation. The method seems to work satismation. The method seems to work satisfactorily in practice but one should always factorily in practice but one should always remember that the aim of the analysis is remember that the aim of the analysis is to evaluate our ability to predict actual to evaluate our ability to predict actual costs and not their logarithms. Values of costs and not their logarithms. Values of R R 2 2 and other indices of concordance of and other indices of concordance of observed and predicted values (see below) observed and predicted values (see below) must be evaluated using the observed and must be evaluated using the observed and predicted costs (not their logarithms). More predicted costs (not their logarithms). More importantly, investigators should be aware importantly, investigators should be aware of the fact that, even though ordinary of the fact that, even though ordinary least-squares methods produce unbiased least-squares methods produce unbiased estimates of log-costs, the predicted actual estimates of log-costs, the predicted actual costs (and also total costs derived from costs (and also total costs derived from the individual predictions) will be biased. the individual predictions) will be biased. They will underestimate the true cost. They will underestimate the true cost. However, bias-reduction methods are availHowever, bias-reduction methods are available (e.g. the non-parametric method called able (e.g. the non-parametric method called 'smearing'; see Duan, 1983) so this under-'smearing'; see Duan, 1983 ) so this underestimation is not a serious problem as long estimation is not a serious problem as long as it is recognised by the investigator. as it is recognised by the investigator.
If the investigator really believes that If the investigator really believes that the relationship between the predictive the relationship between the predictive factors and cost is multiplicative, then it factors and cost is multiplicative, then it is probably preferable to model this exis probably preferable to model this explicitly using an appropriate generalised plicitly using an appropriate generalised linear model. In a generalised linear linear model. In a generalised linear model, the familiar regression equation model, the familiar regression equation of the form of the form þ AE i x i is called the 'linear is called the 'linear predictor'. But the linear predictor is not predictor'. But the linear predictor is not necessarily equated with the expected necessarily equated with the expected cost, as in multiple regression with the cost, as in multiple regression with the raw data, but via 'link function'. So, raw data, but via 'link function'. So, for example, we could have a model in for example, we could have a model in which the natural logarithm of the exwhich the natural logarithm of the expected costs is equated with the linear pected costs is equated with the linear predictor predictor log e ½ECostjXÞ ¼ þ i x i or, equivalently or, equivalently
where 'exp' indicates exponentiation (takwhere 'exp' indicates exponentiation (taking antilogarithms). The form of the model ing antilogarithms).
The form of the model in the final line should make it clear why it in the final line should make it clear why it is a multiplicative model. This generalised is a multiplicative model. This generalised linear model differs from a multiple regreslinear model differs from a multiple regression with logged cost data, however. The sion with logged cost data, however. The first difference is that the errors are first difference is that the errors are assumed to be additive. That is assumed to be additive. That is
The second difference is that there is a more The second difference is that there is a more realistic assumption concerning the probrealistic assumption concerning the probability distribution of the observed costs ability distribution of the observed costs (taking into account that they are non-(taking into account that they are nonnegative, their high degree of skewness negative, their high degree of skewness and their heteroscedasticity). The cost data and their heteroscedasticity). The cost data are usually assumed to follow a gamma disare usually assumed to follow a gamma distribution (potentially highly skewed) and tribution (potentially highly skewed) and the model is fitted by a method called maxthe model is fitted by a method called maximum likelihood rather than ordinary least imum likelihood rather than ordinary least squares. The key similarity between the squares. The key similarity between the ordinary least-squares model for costs and ordinary least-squares model for costs and this generalised linear model, however, is this generalised linear model, however, is that in both we are explicitly modelling that in both we are explicitly modelling the raw costs themselves and not some arbithe raw costs themselves and not some arbitrary transformation of them. A relatively trary transformation of them. A relatively non-technical discussion of generalised non-technical discussion of generalised linear models can be found in Everitt & linear models can be found in . If the investigator chooses . If the investigator chooses to use a one-part model to explain the varto use a one-part model to explain the variation in total costs, then the generalised iation in total costs, then the generalised linear model with a log link (i.e. a log-linear linear model with a log link (i.e. a log-linear model) and gamma errors is likely to promodel) and gamma errors is likely to provide the most realistic description of the vide the most realistic description of the data. For this purpose, ordinary least data. For this purpose, ordinary least squares using raw costs would seem to be squares using raw costs would seem to be unrealistic (in terms of both additive effects unrealistic (in terms of both additive effects and the distribution of the errors) and, and the distribution of the errors) and, apart from its simplicity and familiarity, apart from its simplicity and familiarity, ordinary least squares using logged costs ordinary least squares using logged costs does not appear to have any obvious attracdoes not appear to have any obvious attractions. Again, we defer forecasting until tions. Again, we defer forecasting until later. Recent examples of the use of generlater. Recent examples of the use of generalised linear models in the analysis of menalised linear models in the analysis of mental health care costs can be found in Byford tal health care costs can be found in Byford 
. One very natural extension of the above One very natural extension of the above log-linear generalised linear model is log-linear generalised linear model is through the use of an 'offset'. Suppose that through the use of an 'offset'. Suppose that each patient provided cost data for a differeach patient provided cost data for a different number of years (let this variable be ent number of years (let this variable be called 'Years'). Instead of modelling total called 'Years'). Instead of modelling total costs, suppose that we were also interested costs, suppose that we were also interested in modelling costs per year in modelling costs per year
or or log e ½EðCostjXÞ ¼ log e ½Years þ þ i x i
We still have the same log-linear model We still have the same log-linear model for costs but it now has an extra term, for costs but it now has an extra term, log e ½Years, which is a fixed known con-, which is a fixed known constant for each patient. In the language stant for each patient. In the language of the generalised linear model, an explaof the generalised linear model, an explanatory variable that has a regression conatory variable that has a regression coefficient fixed at unity (rather than it efficient fixed at unity (rather than it being estimated from the data) is called being estimated from the data) is called an offset. Its use perhaps will be more an offset. Its use perhaps will be more familiar (particularly to epidemiologists) familiar (particularly to epidemiologists) in the context of log-linear modelling of in the context of log-linear modelling of disease rates using the so-called persondisease rates using the so-called personyears method (see Armitage years method (see . , 2002).
There is a close link between the use of There is a close link between the use of offsets (person-years) in this way and offsets (person-years) in this way and the survival models in which one handles the survival models in which one handles incomplete follow-up data via censoring. incomplete follow-up data via censoring. This link is also relevant to the analysis This link is also relevant to the analysis of incomplete or censored cost data (see of incomplete or censored cost data (see above). above).
ASSESSING THE MODEL'S ASSESSING THE MODEL'S PERFORMANCE PERFORMANCE
Here we need an index or statistic to meaHere we need an index or statistic to measure the concordance (agreement) between sure the concordance (agreement) between predicted and observed costs. Note that predicted and observed costs. Note that we are not, or should not be, interested in we are not, or should not be, interested in the concordance between predicted and the concordance between predicted and observed log-costs. observed log-costs. Perhaps the simplest index is the familPerhaps the simplest index is the familiar Pearson product-moment correlation iar Pearson product-moment correlation ( (R R) between predicted and observed costs ) between predicted and observed costs , but this is far , but this is far from ideal. It is a measure of association from ideal. It is a measure of association rather than concordance and it is probably rather than concordance and it is probably better to use Lin's concordance coefficient better to use Lin's concordance coefficient ( (R c ; Lin, 1989) or an intraclass correlation ; Lin, 1989) or an intraclass correlation ( (R i ; . But both of these indices, ; . But both of these indices, as well as the product-moment correlation, as well as the product-moment correlation, are dependent on patient heterogeneityare dependent on patient heterogeneitythey will increase with increases in the they will increase with increases in the variability of the costs, irrespective of variability of the costs, irrespective of the accuracy of the predictions. Perhaps the accuracy of the predictions. Perhaps the most commonly used index for a multithe most commonly used index for a multiple regression model is the 'coefficient of ple regression model is the 'coefficient of determination' or 'proportion of variance determination' or 'proportion of variance explained', explained', R 2 (equivalent in this situation (equivalent in this situation to the square of the product-moment correto the square of the product-moment correlation between prediction and obserlation between prediction and observation) -usually obtained from the vation) -usually obtained from the analysis of variance table. But, again, this analysis of variance table. But, again, this is not particularly useful unless the aim is is not particularly useful unless the aim is to discriminate between patients. Like the to discriminate between patients. Like the above correlations, it is dependent on the above correlations, it is dependent on the heterogeneity of the observed costs. Despite heterogeneity of the observed costs. Despite this potential disadvantage, however, they this potential disadvantage, however, they are obviously useful for comparison of the are obviously useful for comparison of the performance of various models for the same performance of various models for the same data. Problems only arise when we try to data. Problems only arise when we try to compare the performance of predictive compare the performance of predictive models on different groups. 
Þðn À 1Þ=ðn À pÞ and and n is the number of patients in the samis the number of patients in the sample and ple and p is the number of estimated parais the number of estimated parameters (including the intercept term). The meters (including the intercept term). The idea is that the adjusted idea is that the adjusted R 2 provides a provides a better estimate of the likely performance better estimate of the likely performance of the model on future data-sets. Draper of the model on future data-sets. Draper & Smith (1998) comment that & Smith (1998) comment that 'The value of this statistic for the latter purpose 'The value of this statistic for the latter purpose is, in our opinion, not high; is, in our opinion, not high; R R a a 2 2 might be useful as might be useful as an initial gross indicator, but this is all' an initial gross indicator, but this is all' (see the section on cross-validation below). (see the section on cross-validation below). The use of The use of R 2 a instead of instead of R 2 , however, may , however, may lead to less overfitting because lead to less overfitting because R 2 a is a is a penalised goodness-of-fit index that is penalised goodness-of-fit index that is dependent on the number of estimated dependent on the number of estimated parameters ( parameters (p) in addition to the propor-) in addition to the proportion of the total sum of squares explained. tion of the total sum of squares explained. Unlike Unlike R 2 , which cannot decrease as , which cannot decrease as p increases (i.e. when a variable is added, increases (i.e. when a variable is added, the explained sum of squares will either the explained sum of squares will either increase or stay the same), the value of increase or stay the same), the value of R 2 a can actually decrease when extra variables can actually decrease when extra variables are added to the model (as in the case of are added to the model (as in the case of overfitting; . overfitting; .
The accuracy of a model's predictions is The accuracy of a model's predictions is probably best evaluated by a function of the probably best evaluated by a function of the differences between the predicted and obdifferences between the predicted and observed costs. That is, by a function of served costs. That is, by a function of ( (c o À c p ), where ), where c o is the observed cost for is the observed cost for a given patient and a given patient and c p is the corresponding is the corresponding prediction: prediction: EðCostjXÞ. The three obvious . The three obvious choices are the residual mean square choices are the residual mean square (RMS), root-mean-square error (RMSE) (RMS), root-mean-square error (RMSE) and the mean of the absolute error and the mean of the absolute error (MAE). A less familiar index is Theil's (MAE). A less familiar index is Theil's U U-statistic .
-statistic . The RMSE is the square root of the The RMSE is the square root of the mean of the squared differences between mean of the squared differences between the predicted and observed values of cost, the predicted and observed values of cost, MAE is the mean of the absolute value of MAE is the mean of the absolute value of the differences, and RMS is the residual the differences, and RMS is the residual sum of squares divided by the residual sum of squares divided by the residual degrees of freedom as obtained from the degrees of freedom as obtained from the relevant analysis of variance table. The relevant analysis of variance table. The square root of the RMS (i.e. the standard square root of the RMS (i.e. the standard deviation of the residuals) is likely to be deviation of the residuals) is likely to be close but not identical to the RMSE. Theil's close but not identical to the RMSE. Theil's U U-statistic is the square root of the sum of -statistic is the square root of the sum of the squared deviations of the predicted the squared deviations of the predicted from the observed costs divided by the from the observed costs divided by the square root of the sum of the squared presquare root of the sum of the squared predictions. Algebraically, the less familiar of dictions. Algebraically, the less familiar of these indices are defined as follows these indices are defined as follows
Some authors use Some authors use
In all four cases the addition (indicated by In all four cases the addition (indicated by the symbol the symbol AE) is over all patients in the ) is over all patients in the sample, and a value of zero for the index sample, and a value of zero for the index indicates perfect prediction. Index indicates perfect prediction. Index U, like , like the various correlation coefficients and the various correlation coefficients and R 2 , is a scale-free measure of concord-, is a scale-free measure of concordance and shares the same advantages and ance and shares the same advantages and pitfalls. pitfalls.
One potential problem, whatever indiOne potential problem, whatever indicator of performance is used, is that if it is cator of performance is used, is that if it is used naively it is likely to be overoptimistic. used naively it is likely to be overoptimistic. If the explanatory variables in the final If the explanatory variables in the final model have been chosen using the same model have been chosen using the same data as those used to assess the model's data as those used to assess the model's performance, then we are likely to have performance, then we are likely to have capitalised on chance associations between capitalised on chance associations between potential explanatory variables and the cost potential explanatory variables and the cost outcomes and inevitably will have prooutcomes and inevitably will have produced a model that has been overfitted duced a model that has been overfitted . A more realistic evaluation . A more realistic evaluation of the performance of the model ideally of the performance of the model ideally should be made by cross-validation using should be made by cross-validation using a data-set collected from a second, indepena data-set collected from a second, independent sample of patients. Unfortunately, dent sample of patients. Unfortunately, however, we often do not have adequate rehowever, we often do not have adequate resources within a particular research project sources within a particular research project to be able to collect such a data-set, and if to be able to collect such a data-set, and if we test our model on someone else's data we test our model on someone else's data it is unlikely that they will have collected it is unlikely that they will have collected exactly the same information using the exactly the same information using the same measurement procedures on a comsame measurement procedures on a comparable sample of patients. A more realistic parable sample of patients. A more realistic option is to split our original sample into option is to split our original sample into two, develop the model on one of the two, develop the model on one of the subsamples (the so-called training set) and subsamples (the so-called training set) and evaluate it using the second one (the evaluate it using the second one (the validation set). This split-sample or internal validation set). This split-sample or internal approach to cross-validation is the one approach to cross-validation is the one advocated by Diehr advocated by Diehr et al et al (1999) and (1999) and illustrated in Kilian illustrated in Kilian et al et al (2002 Kilian et al et al ( ). (2002 . One pitfall of the split-half approach is One pitfall of the split-half approach is its inefficient use of the data. Unless we its inefficient use of the data. Unless we have a very large sample to start with, we have a very large sample to start with, we are usually loath to use only half of the are usually loath to use only half of the patients to develop the model and half to patients to develop the model and half to test it. Ideally, we would like to maximise test it. Ideally, we would like to maximise the use of the data for both functions. the use of the data for both functions. One approach is to take the full sample of One approach is to take the full sample of n n patients and leave each of the patients patients and leave each of the patients out in turn. Each time, we derive a model out in turn. Each time, we derive a model from the from the n À 1 remaining patients and test remaining patients and test its performance on the one that has been its performance on the one that has been left out. This 'leave-one-out' procedure in left out. This 'leave-one-out' procedure in principle involves a separate analyses from principle involves a separate analyses from which we can then produce an overall which we can then produce an overall summary of the model's performance. In summary of the model's performance. In practice this will not be necessary, but the practice this will not be necessary, but the technical details are beyond the scope of technical details are beyond the scope of the present discussion. The text by Mostelthe present discussion. The text by contains a nice introler & Tukey (1977) contains a nice introduction to cross-validation methods and duction to cross-validation methods and Armitage Armitage et al et al ( : p. 395) provides a (2002 ) provides a brief discussion of variants of the leavebrief discussion of variants of the leaveone-out method (see also Picard & Berk, one-out method (see also . 1990).
HOW ROBUST ARE THE HOW ROBUST ARE THE STATISTICAL METHODS ? STATISTICAL METHODS ?
Returning to the simple ordinary leastReturning to the simple ordinary leastsquares multiple regression models for obsquares multiple regression models for observed costs, how can we be confident that served costs, how can we be confident that inferences based on such a model are safe? inferences based on such a model are safe? We know because of the skewness (nonWe know because of the skewness (nonnormality) and heteroscedasticity of the normality) and heteroscedasticity of the data that ordinary least-squares regression data that ordinary least-squares regression is not optimal. How does this affect the is not optimal. How does this affect the model's parameter estimates, their standard model's parameter estimates, their standard errors, errors, P P values, confidence intervals, etc.? values, confidence intervals, etc.? Safe statistical inference for these models Safe statistical inference for these models rests on the assumption that on repeated rests on the assumption that on repeated sampling the parameter estimates would sampling the parameter estimates would be normally distributed. This is likely to be normally distributed. This is likely to be the case for large samples but frequently be the case for large samples but frequently we have doubts about whether our sample we have doubts about whether our sample is large enough. In the context of the analyis large enough. In the context of the analysis of cost data from a randomised trial, sis of cost data from a randomised trial, Barber & Thompson (2000 Barber & Thompson (2000a see also ; see also Desgagne Desgagné et al et al, 1998) have advocated the , 1998) have advocated the use of distribution-free procedures based use of distribution-free procedures based on a resampling procedure called the booton a resampling procedure called the bootstrap . They strap . They claim that the bootstrap will provide robust claim that the bootstrap will provide robust inferences that are not dependent on distriinferences that are not dependent on distributional assumptions. They conclude that butional assumptions. They conclude that 'such bootstrap techniques can be recom-'such bootstrap techniques can be recommended either as a check on the robustness of mended either as a check on the robustness of standard parametric methods, or to provide the standard parametric methods, or to provide the primary statistical analysis when making inferprimary statistical analysis when making inferences about arithmetic means for moderately ences about arithmetic means for moderately sized samples of highly skewed data such as costs' sized samples of highly skewed data such as costs' (Barber & Thompson, 2000 (Barber & Thompson, 2000b . ).
The use of bootstrapping now appears to be The use of bootstrapping now appears to be commonplace in health economics studies, commonplace in health economics studies, but is it the panacea that many health but is it the panacea that many health economists appear to believe it is? economists appear to believe it is?
Barber & Thompson's claims concernBarber & Thompson's claims concerning the robustness of the inferences based ing the robustness of the inferences based on the bootstrap have been challenged reon the bootstrap have been challenged recently by . They cently by . They point out that for highly skewed cost data point out that for highly skewed cost data obtained from small samples of patients obtained from small samples of patients the sample mean is not the ideal estimator the sample mean is not the ideal estimator of the required population mean. It is very of the required population mean. It is very sensitive to the presence of one or two sensitive to the presence of one or two stragglers with relatively high costs, and instragglers with relatively high costs, and inferences based on bootstrapping the sample ferences based on bootstrapping the sample mean will be equally affected by this probmean will be equally affected by this problem. They argue that even when the methlem. They argue that even when the methods advocated by Barber & Thompson ods advocated by Barber & Thompson are technically valid (in terms of their large are technically valid (in terms of their large sample properties), in small samples they sample properties), in small samples they may lead to inefficient and even misleading may lead to inefficient and even misleading inferences. We suspect that this is likely to inferences. We suspect that this is likely to be an even greater problem for ordinary be an even greater problem for ordinary least-squares-based multiple regression least-squares-based multiple regression models. O Berk, tions (Mosteller & Tukey, 1977; . Note that robust fitting methods 1990). Note that robust fitting methods should not be confused with robust methshould not be confused with robust methods of standard error estimation (the bootods of standard error estimation (the bootstrap, for example) once we have got our strap, for example) once we have got our best-fitting model. They are complementary best-fitting model. They are complementary and should not be seen as competitors. A and should not be seen as competitors. A recent health economics application of recent health economics application of robust model-fitting methodology can be robust model-fitting methodology can be found in Hoch found in Hoch et al et al (2002) .
DISCUSSION DISCUSSION

Choice of model Choice of model
It is our experience and that of others It is our experience and that of others (Diehr (Diehr et al et al, 1999; Kilian , 1999; Kilian et al et al, 2002 Kilian et al et al, ) that, , 2002 ) that, as a method of prediction (forecasting), a as a method of prediction (forecasting), a one-part model involving ordinary leastone-part model involving ordinary leastsquares on raw costs data consistently persquares on raw costs data consistently performs as well as, if not better than, ordinary forms as well as, if not better than, ordinary least squares on logged costs or the more least squares on logged costs or the more theoretically satisfying log-linear generaltheoretically satisfying log-linear generalised linear model. The former sometimes ised linear model. The former sometimes produces negative cost estimates but this produces negative cost estimates but this is not a serious problem. We provisionally is not a serious problem. We provisionally follow Diehr follow Diehr et al et al (1999 Diehr et al et al ( ) in recommending (1999 in recommending the use of ordinary least-squares regression the use of ordinary least-squares regression with raw costs for this purpose. However, with raw costs for this purpose. However, the use of methods that pay more attention the use of methods that pay more attention to the distribution of the costs data, or the to the distribution of the costs data, or the use of robust model-fitting algorithms, is use of robust model-fitting algorithms, is likely to produce improvements over the likely to produce improvements over the use of ordinary least squares. If research use of ordinary least squares. If research workers are primarily interested in explanaworkers are primarily interested in explanatory modelling and if they think that their tory modelling and if they think that their model should be multiplicative, then they model should be multiplicative, then they should seriously consider the use of a genershould seriously consider the use of a generalised linear model with a logarithmic link alised linear model with a logarithmic link function (i.e. a log-linear model) with an function (i.e. a log-linear model) with an appropriately specified error distribution. appropriately specified error distribution. But even more value as an explanatory tool But even more value as an explanatory tool might be the use of two-part models. Bootmight be the use of two-part models. Bootstrapping is a very useful all-purpose and strapping is a very useful all-purpose and distribution-free method of obtaining distribution-free method of obtaining standard errors, confidence and standard errors, confidence and P P values, values, but its use should not replace the careful but its use should not replace the careful thought that should be given to the choice thought that should be given to the choice of the type of model to be fitted and the of the type of model to be fitted and the optimum model-fitting algorithm to be optimum model-fitting algorithm to be used once the model type has been chosen. used once the model type has been chosen. Bootstrapping comes later. Bootstrapping comes later.
Assessing the performance Assessing the performance of the model of the model
We do not recommend the use of standardWe do not recommend the use of standardised indices such as ised indices such as R 2 or Theil's or Theil's U-statistic -statistic to compare the performance of a model to compare the performance of a model when applied to when applied to different different groups. The groups. The apparent lack of predictive value for paapparent lack of predictive value for patients in one particular group (group 1), tients in one particular group (group 1), for example, as opposed to that in another for example, as opposed to that in another (group 2) may simply be a statistical arte-(group 2) may simply be a statistical artefact caused by the fact that there is less fact caused by the fact that there is less variability in the costs for the patients in variability in the costs for the patients in group 2. The performance of the forecasts group 2. The performance of the forecasts (as measured by root-mean-square error (as measured by root-mean-square error or mean absolute error) may, in fact, be or mean absolute error) may, in fact, be better in group 2 than in group 1. The main better in group 2 than in group 1. The main advantage of advantage of R 2 and Theil's and Theil's U-statistic is to -statistic is to compare the performance of competing compare the performance of competing models within the models within the same same group of patients. group of patients. For comparison of the performance of For comparison of the performance of models on different groups, we recommend models on different groups, we recommend the use of the root-mean-square error or the use of the root-mean-square error or mean absolute error. Finally, we stress the mean absolute error. Finally, we stress the importance of cross-validation -how well importance of cross-validation -how well will the model perform in a future sample? will the model perform in a future sample?
Something old, something new, something borrowed, Something old, something new, something borrowed, something blue: a framework for the marriage of health something blue: a framework for the marriage of health econometrics and cost-effectiveness analysis. econometrics and cost-effectiveness analysis. Health Health Economics Economics, , 11 11, 415^430. , 415^430.
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CLINICAL IMPLICATIONS CLINICAL IMPLICATIONS
& & This paper provides a relatively non-technical introduction to statistical regression This paper provides a relatively non-technical introduction to statistical regression models for mental health cost data for research workers, clinicians and mental health models for mental health cost data for research workers, clinicians and mental health workers. workers.
& & Different models are described according to the goal of a study. A given statistical Different models are described according to the goal of a study. A given statistical model might be good as an explanatory device but poor as a tool for forecasting or model might be good as an explanatory device but poor as a tool for forecasting or vice versa. vice versa. In the analysis of mental health cost data, clear and easily interpretable indices of the performance of a model are proposed. Clinicians and health managers are the performance of a model are proposed. Clinicians and health managers are interested in indices that measure the difference between predicted and observed interested in indices that measure the difference between predicted and observed costs, rather than in their concordance or association. costs, rather than in their concordance or association.
LIMITATIONS LIMITATIONS
& & We have not dwelt on many of the technical details but give only a brief summary.
We have not dwelt on many of the technical details but give only a brief summary. We refer interested readers to other publications. We refer interested readers to other publications. We pay only limited attention to cost-effectiveness data.
